.....there are 11 available positions with Insmed. Go to their website and read up on them. There appears to be strong optimism at work here.
Perhaps they are assuming far too much from the fact that -
1. Once daily Arikace was as safe and effective as twice daily Tobi in its pivotal European Phase III clinical trial.
2. Once daily Arikace delivered sustained efficacy for a year (and counting) - the first inhaled antibiotic ever to do so.
3. The long-term toxicity studies in rats and dogs are already done and dusted.
I'm appalled Insmed should take European sales for granted on the basis of such flimsy evidence :-)
Now that is a real news story...not fake...WOW.